2nd Controlled & Modified Drug Release 2015 is a conference dedicated to Novel Formulation Approaches, Delivery Technologies, Regulatory Updates & Strategies to Accelerate Drug Product Time-To-Market.
- New approaches in modified release / modeling & simulation in modified release
- FDA guidance on pharmacokinetics and clinical evaluation of sustained & modified release dosage forms
- Pre-investment in control release
- Right conditions for IVIVC correlation
- Dissolution applications within controlled release
- In-licensing / out-licensing strategy
- Application of in-vivo and in-silico modeling
- Quality by Design Example for. Generic Modified Release Drug Products
- Techniques for drug delivery: Systems and targeted drug delivery
- Next generation products
- Topical and Transdermal Delivery
- Parenteral controlled & sustained release
- New formulations hot-melt extrusion technology development to optimize sustained delivery
- Rational design of drug delivery systems for poorly water soluble drugs
Who should Attend
Attendees with responsibilities in:
- Pharmaceutics
- Drug Delivery
- Physiochemistry
- PK-PD
- Pre-Formulation
- Formulation
- Analytical
- Medicinal
- Preclinical
- Solid state Chemistry
- Product Enhancement
- Analytical Development
- CMC
- Development
- Drug Discovery
- Regulatory Affairs
- Partnering
- Life-Cycle / Portfolio Management
- Intellectual Property
- Licensing & Alliance Management
- Process R&D
- Toxicology
